Back

Antidiabetic agents in lower extremity artery disease: save the patient? Save the limb?

25 August 2018 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice? Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Mislav Vrsalovic

University Hospital Sestre Milosrdnice, Zagreb (Croatia)

3 More presentations in this session

Presentation thumbnail
The COMPASS trial: a new paradigm in lower extremity artery disease?
Professor O. Berwanger (London, GB)
Slides Video
Presentation thumbnail
Lipid lowering therapy in peripheral vascular disease. Which targets? Which drugs?
Doctor I. Desormais (Limoges, FR)
Slides Video
Presentation thumbnail
Revascularisation in peripheral artery disease
Professor M. Venermo (Helsinki, FI)
Slides Video

Access the full session

Session thumbnail
Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice?

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Influence of therapy in patients with CAD and type 2 diabetes on inflamation biomarkers P-selectin and Galectin-3 changes
20 May 2023
thumbnail
Congress Presentation
Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease: rationale and design of the STRIDE trial
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources